comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 21:07:39 - browse：999

UnitedHealth CEO Andrew Witty testifies before the Senate Finance Committee on Capitol Hill on May 1, 2024 in Washington — Kent Nishimura/Getty Images

Change Healthcare can notify patients whose sensitive health information has been exposed as a result of the massive security breach at the health care payments clearinghouse in February, the Department of Health and Human Services said Friday.

This long-awaited update from the federal agency answers questions from hospitals and doctors around the country, who were worried they would have to track down the roughly 30% of Americans whose data may have been stolen. Federal law requires health care providers to inform patients when their data has been exposed.

Just last week, over 100 provider industry groups sent a letter to HHS secretary Xavier Becerra asking the agency’s Office of Civil Rights, which handles HIPAA data breaches, to clarify that Change Healthcare and its parent company UnitedHealth Group are responsible for finding and notifying affected customers, not individual hospitals, doctors’ offices, and other health care providers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： STAT Summit: Ending the crisis of Black deaths in the U.S.

WSS

Questions loom on AstraZeneca cancer drug as safety concerns ebb

The problems with dementia villages

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Why a market frenzy over new weight loss drugs defies logic

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

knowledge

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Too many hospitalized Covid

Affirmative action in medical school literally saved lives

Too many hospitalized Covid

Medical leaders decry Supreme Court decision on affirmative action

How AI can help patients find reliable information about doctors

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

As demand for Covid shots wanes, Moderna seeks its next success

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

knowledge

Why don't Americans have at

Study gives hint on South Asians’ higher risk of cardiovascular disease

Resistance to opioid

Readout Newsletter: Amylyx, Aurinia, and IQVIA

J&J lung cancer data amount to new salvo against AstraZeneca

Bernie Sanders gets little from pharma CEOs on drug prices

knowledge

focus

entertainment

hotspot